Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$37,485.75
Jun 2, 2026
For-profit organization
MHCombiotic Inc.-2026-2027-1044010
1044010
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$75,000.00
Dec 15, 2025
For-profit organization
Wound Healing Study for ComBatic™ Antimicrobial Wound Kit
1038084
MHCombiotic will conduct a GLP-level porcine wound study to evaluate ComBatic Antimicrobial Wound Hydrogel and Irrigation Solution. One pig with ten standardized full thickness dorsal wounds will be treated across test, predicate, and control arms. Endpoints include wound area reduction, epithelialization, exudate scoring, local tissue tolerance, and histology. Results will define safe dosing and treatment frequency, benchmark performance versus a marketed cleanser, and generate regulatory grade evidence to support Health Canada Class II and FDA 510(k) submissions.
$75,000.00
Aug 1, 2024
For-profit organization
Finalization of Production, Manufacturing, Packaging, Product Development and Systems Controls
1022802
The project funding will support the firm researching, developing, optimizing production, testing product packaging, testing of product stability under shipping conditions, and scaling the firm's manufacturing processes to produce its Wound Care products at commercial scale.
$9,000.00
Apr 15, 2024
For-profit organization
MHCombiotic Inc.-2024-2025-1018475
1018475
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$60,000.00
Oct 1, 2023
For-profit organization
Youth Project - MHCombiotic 2 Youth positions
1011919
The proposed project aims to develop an innovative solution for complex non-healing wounds by
creating an antimicrobial wound kit that prevents wound infection, treats various types of wound
infections, and promotes the healing process. The kit has undergone extensive preclinical surveys by
conducting over 18,000 tests to evaluate its efficacy and safety, positioning it well for the next stages of
development. The kit is a combination of novel antimicrobial agents that work synergistically to kill
bacteria and prevent the formation of biofilms, which is a common complication in chronic wound
infections that impede healing.